Mackenzie Financial
CORV

Mackenzie Financial’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Mackenzie Financial’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-76,300
Closed -$391K – 893
2016
Q2 		$391K Hold
76,300
– – ﹤0.01% 793
2016
Q1 		$312K Hold
76,300
– – ﹤0.01% 728
2015
Q4 		$619K Buy
76,300
+7,700
+11% +$64.2K ﹤0.01% 625
2015
Q3 		$579K Buy
68,600
+18,100
+36% +$167K ﹤0.01% 636
2015
Q2 		$475K Buy
50,500
+2,800
+6% +$26.1K ﹤0.01% 684
2015
Q1 		$442K Buy
47,700
+10,700
+29% +$102K ﹤0.01% 677
2014
Q4 		$342K Buy
37,000
+18,600
+101% +$157K ﹤0.01% 680
2014
Q3 		$164K Buy
+18,400
New +$134K ﹤0.01% 708

Other funds holding CORV

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIS
AlphaOne Investment Services West Chester, Pennsylvania $79.5M AUM 49.42% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mackenzie Financial's CORV Position: Q3 2016 in Review

Mackenzie Financial sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q3 2016, closing a stake of 76,300 shares — an estimated $391K sold.

Mackenzie Financial first reported a position in CORV in Q3 2014 and held it in 8 quarters. The position peaked at $619K in Q4 2015. 33 funds tracked by Wall St. Rank hold CORV as of Q3 2016.

  • Mackenzie Financial reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q3 2016 after selling out during the quarter.
  • Mackenzie Financial sold 76,300 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q3 2016, an estimated $391K.
  • Mackenzie Financial first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q3 2014 and held it in 8 quarters.
  • Mackenzie Financial's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $619K in Q4 2015.
  • 33 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q3 2016.

Based on Mackenzie Financial's 13F filing for Q3 2016, filed 15 Nov 2016.